Do You Think the Point Trial Is the Best Way to Go About It?

The chance trial was performed first in eastasian populations and then more recently replicated in the form of the point trial. Both were positive in comparing aspon and copertigal versus aspirat alone for minor stroke and high risk t i a within the first 24 hours of symptom onset. Am what what seems if you sort of look at the actual curves of the event rates and of the complication rates, it seems like the greatest bang for your buck comes with shorter than 90 days.